Drugs from A to Z
187 drugs with at least one EU-approved cancer indication, other than classic chemotherapy. Biosimilars and generics are listed on the page of the reference drug.
A
- AbemaciclibVerzenios, 3 indications
- AbirateroneAbiraterone Krka, Zytiga, 3 indications
- AcalabrutinibCalquence, 6 indications
- AdagrasibKrazati, 1 indication
- AfatinibGiotrif, 2 indications
- AfliberceptZaltrap, 1 indication
- AlectinibAlecensa, 3 indications
- AlpelisibPiqray, 1 indication
- AmivantamabRybrevant, 4 indications
- ApalutamideErleada, 2 indications
- Arsenic trioxideTrisenox, 4 indications
- AsciminibScemblix, 2 indications
- AtezolizumabTecentriq, 13 indications
- AvapritinibAyvakyt, 3 indications
- AvelumabBavencio, 3 indications
- Axicabtagene ciloleucelYescarta, 3 indications
- AxitinibInlyta, 1 indication
B
- Belantamab mafodotinBlenrep, 2 indications
- BelzutifanWelireg, 4 indications
- BevacizumabAvastin, 10 indications
- BexaroteneTargretin, 1 indication
- BinimetinibMektovi, 2 indications
- BlinatumomabBlincyto, 6 indications
- BortezomibVelcade, 5 indications
- BosutinibBosulif, 3 indications
- Brentuximab vedotinAdcetris, 7 indications
- Brexucabtagene autoleucelTecartus, 2 indications
- BrigatinibAlunbrig, 2 indications
C
- CabozantinibCabometyx, Cometriq, 7 indications
- CamizestrantEtcamah, 1 indication
- CapivasertibTruqap, 1 indication
- CapmatinibTabrecta, 1 indication
- CarfilzomibKyprolis, 3 indications
- CatumaxomabKorjuny, 1 indication
- CemiplimabLibtayo, 6 indications
- CeritinibZykadia, 2 indications
- CetuximabErbitux, 7 indications
- Ciltacabtagene autoleucelCarvykti, 1 indication
- CobimetinibCotellic, 1 indication
- CrizotinibXalkori, 5 indications
D
- DabrafenibFinlee, Tafinlar, 7 indications
- DacomitinibVizimpro, 1 indication
- DaratumumabDarzalex, 8 indications
- DarolutamideNubeqa, 3 indications
- DasatinibDasatinib Accord Healthcare, Sprycel, 7 indications
- Datopotamab deruxtecanDatroway, 2 indications
- DegarelixFirmagon, 3 indications
- Dinutuximab betaQarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), 3 indications
- DostarlimabJemperli, 2 indications
- DurvalumabImfinzi, 16 indications
E
- ElacestrantOrserdu, 1 indication
- ElotuzumabEmpliciti, 2 indications
- ElranatamabElrexfio, 1 indication
- EncorafenibBraftovi, 4 indications
- Enfortumab vedotinPadcev, 4 indications
- EntrectinibRozlytrek, 2 indications
- EnzalutamideXtandi, 6 indications
- EpcoritamabTepkinly, 3 indications
- ErdafitinibBalversa, 1 indication
- ErlotinibTarceva, 5 indications
- EverolimusAfinitor, Votubia, 6 indications
F
G
I
- IbrutinibImbruvica, 11 indications
- Idecabtagene vicleucelAbecma, 1 indication
- IdelalisibZydelig, 3 indications
- ImatinibGlivec, 9 indications
- ImetelstatRytelo, 1 indication
- ImlunestrantInluriyo, 1 indication
- InavolisibItovebi, 1 indication
- Inotuzumab ozogamicinBesponsa, 2 indications
- IpilimumabYervoy, 9 indications
- IsatuximabSarclisa, 4 indications
- IvosidenibTibsovo, 2 indications
- IxazomibNinlaro, 1 indication
L
- LapatinibTyverb, 3 indications
- LarotrectinibVitrakvi, 1 indication
- LazertinibLazcluze, 1 indication
- LenalidomideRevlimid, 6 indications
- LenvatinibKisplyx, Lenvima, 5 indications
- LeuprorelinCamcevi, 2 indications
- LinvoseltamabLynozyfic, 1 indication
- Lisocabtagene maraleucelBreyanzi, 5 indications
- Loncastuximab tesirineZynlonta, 1 indication
- LorlatinibLorviqua, 2 indications
- LurbinectedinZepzelca, 1 indication
- Lutetium (177Lu) oxodotreotideLutathera, 1 indication
- Lutetium (177Lu) vipivotide tetraxetanPluvicto, 1 indication
M
N
- Nadofaragene firadenovecAdstiladrin, 1 indication
- NeratinibNerlynx, 1 indication
- NilotinibTasigna, 3 indications
- NintedanibVargatef, 1 indication
- NiraparibZejula, 2 indications
- Niraparib + abirateroneAkeega, 2 indications
- NirogacestatOgsiveo, 1 indication
- NivolumabOpdivo, 28 indications
- Nogapendekin alfa inbakiceptAnktiva, 1 indication
O
P
- PalbociclibIbrance, 2 indications
- PanitumumabVectibix, 3 indications
- PanobinostatFarydak, 1 indication
- PazopanibVotrient, 3 indications
- Peginterferon alfa-2aPegasys, 1 indication
- PembrolizumabKeytruda, 42 indications
- PemigatinibPemazyre, 1 indication
- PertuzumabPerjeta, 3 indications
- Pertuzumab + trastuzumabPhesgo, 3 indications
- PirtobrutinibJaypirca, 2 indications
- Polatuzumab vedotinPolivy, 2 indications
- PomalidomideImnovid (previously Pomalidomide Celgene), 2 indications
- PonatinibIclusig, 7 indications
Q
R
- Radium Ra223 dichlorideXofigo, 2 indications
- RamucirumabCyramza, 6 indications
- RegorafenibStivarga, 3 indications
- Relatlimab + nivolumabOpdualag, 1 indication
- RelugolixOrgovyx, 1 indication
- RepotrectinibAugtyro, 2 indications
- RetifanlimabZynyz, 2 indications
- RibociclibKisqali, 3 indications
- RipretinibQinlock, 1 indication
- RituximabMabThera, 8 indications
- Ropeginterferon alfa-2bBesremi, 1 indication
- RucaparibRubraca, 2 indications
- RuxolitinibJakavi, Ruxolitinib Viatris, 2 indications
S
- Sacituzumab govitecanTrodelvy, 4 indications
- SelinexorNexpovio, 2 indications
- SelpercatinibRetsevmo, 4 indications
- SelumetinibKoselugo, 2 indications
- SerplulimabHetronifly, 4 indications
- SonidegibOdomzo, 1 indication
- SorafenibNexavar, 3 indications
- SotorasibLumykras, 1 indication
- SugemalimabCejemly, 2 indications
- SunitinibSutent, 3 indications
T
- TabelecleucelEbvallo, 1 indication
- TafasitamabMinjuvi, 2 indications
- TagraxofuspElzonris, 1 indication
- TalazoparibTalzenna, 2 indications
- Talimogene laherparepvecImlygic, 1 indication
- TalquetamabTalvey, 1 indication
- TarlatamabImdylltra, 1 indication
- TasonerminBeromun, 1 indication
- TebentafuspKimmtrak, 1 indication
- TeclistamabTecvayli, 2 indications
- TemsirolimusTorisel, 2 indications
- TepotinibTepmetko, 1 indication
- ThalidomideThalidomide BMS (previously Thalidomide Celgene), Thalidomide Lipomed, 1 indication
- TisagenlecleucelKymriah, 3 indications
- TislelizumabTevimbra, 10 indications
- Tisotumab vedotinTivdak, 1 indication
- TivozanibFotivda, 2 indications
- ToremifeneFareston, 1 indication
- ToripalimabLoqtorzi, 2 indications
- TovorafenibOjemda, 2 indications
- TrametinibMekinist, Spexotras, 7 indications
- TrastuzumabHerceptin, Tuznue, 10 indications
- Trastuzumab deruxtecanEnhertu, 7 indications
- Trastuzumab emtansineKadcyla, 2 indications
- TremelimumabImjudo, 2 indications
- TucatinibTukysa, 1 indication